5-bromo-4-chloro-6-methylthieno[2,3-d]pyrimidine

Catalog No.: 
ACPGXF503
CAS No.: 
1388892-94-1
Molecular Formula: 
C7H4BrClN2S
Molecular Weight: 
263.55
5-bromo-4-chloro-6-methylthieno[2,3-d]pyrimidine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$459.00InquiryInquiry
250mg95%$747.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-bromo-4-chloro-6-methylthieno[2,3-d]pyrimidine
IUPAC Name5-bromo-4-chloro-6-methylthieno[2,3-d]pyrimidine
MDL No.MFCD22987600
Molecular FormulaC7H4BrClN2S
Molecular Weight263.55
SMILESCC1=C(Br)C2=C(Cl)N=CN=C2S1
InChI KeyDJIDMQBJWKUZRQ-UHFFFAOYSA-N
Synonym5-bromo-4-chloro-6-methylthieno[2,3-d]pyrimidine | 1388892-94-1 | SCHEMBL10325524 | MFCD22987600 | BS-43384 | P18837
CAS No.1388892-94-1
PubChem CID86673334

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACPGXF503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPGXF503 route product structure diagram
    ACPGXF5031388892-94-1
Inquiry

2. ACPGXF503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPGXF503 route product structure diagram
    ACPGXF5031388892-94-1
Inquiry

3. ACPGXF503 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACPGXF503 route product structure diagram
    ACPGXF5031388892-94-1
Inquiry

Comments (0)